Page last updated: 2024-09-05

4-n-butylresorcinol and Hyperpigmentation

4-n-butylresorcinol has been researched along with Hyperpigmentation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
De Keyser, E; Lapeere, H1
Ahlheit, S; Batzer, J; Gerwat, W; Kolbe, L; Mann, T; Scherner, C; Stäb, F; Wenck, H1

Trials

1 trial(s) available for 4-n-butylresorcinol and Hyperpigmentation

ArticleYear
4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27 Suppl 1

    Topics: Administration, Topical; Aged; Arbutin; Female; Humans; Hydroquinones; Hyperpigmentation; Melanins; Middle Aged; Monophenol Monooxygenase; Pyrones; Resorcinols; Single-Blind Method; Skin; Skin Lightening Preparations; Tissue Culture Techniques; Treatment Outcome

2013

Other Studies

1 other study(ies) available for 4-n-butylresorcinol and Hyperpigmentation

ArticleYear
Allergic contact dermatitis caused by 4-n-butylresorcinol present in a night cream for skin hyperpigmentation.
    Contact dermatitis, 2020, Volume: 83, Issue:2

    Topics: Dermatitis, Allergic Contact; Eczema; Facial Dermatoses; Female; Humans; Hyperpigmentation; Middle Aged; Neck; Resorcinols; Skin Cream; Thorax

2020